| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |